Wayne L. Miller et al. JCHF 2013;1:

Slides:

Advertisements

Similar presentations

Picture of my family – love to start talks in the comfort of my living room. Feel passionate about my girls and about this unique population of patients.

Advertisements

From: Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.

From: Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.

Hemodynamic classification of pulmonary hypertension (PH)

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Left Ventricular Dysfunction With Pulmonary Hypertension

Noriko Kikuchi et al. JACEP 2016;2:

Patrizio Lancellotti et al. JIMG 2016;9:

Exercise-Induced Pulmonary Hypertension

Shadi Al Halabi et al. JACEP 2015;1:

Nat. Rev. Cardiol. doi: /nrcardio

G. Michael Felker et al. JCHF 2014;2:

Carolyn Y. Ho et al. JCHF 2015;3:

Alan G. Japp et al. JACC 2016;67: Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.

Johannes Steiner et al. JACC 2017;70:

Johannes Steiner et al. JACC 2017;70:

Caroline Zotter-Tufaro et al. JCHF 2015;3:

Nat. Rev. Cardiol. doi: /nrcardio

John E. Sanderson JCHF 2014;2:93-94

David F. Katz et al. JACEP 2016;j.jacep

Johannes Steiner et al. JACC 2017;70:

Giuseppe Boriani et al. JACEP 2016;2:

Mohit K. Turagam et al. JACEP 2017;3:

Algorithm for the diagnosis and treatment of portopulmonary hypertension (POPH). Algorithm for the diagnosis and treatment of portopulmonary hypertension.

Mintu P. Turakhia et al. JACEP 2016;2:

Jordan B. King et al. JCHF 2016;4:

G. Michael Felker et al. JCHF 2014;2:

Svend A. Mortensen et al. JCHF 2014;2:

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018 Stephan Rosenkranz, Irene.

Yoshitaka Kimura et al. JACEP 2016;2:

David F. Katz et al. JACEP 2017;3:20-28

Connie W. Tsao et al. JCHF 2016;4:

Neal A. Chatterjee et al. JCHF 2014;2:

Peter E. Carson et al. JCHF 2015;3:

Maria R. Costanzo et al. JCHF 2016;4:

Mintu P. Turakhia et al. JACEP 2016;2:

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

Rami Doukky et al. JCHF 2016;4:24-35

Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.

Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

Associations between β-blocker dosage group, predischarge heart rate group, and the primary composite outcome of death or cardiovascular rehospitalisation.

John Rickard et al. JCHF 2013;1:

Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf

(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Figure 3. Survival rates according to renal dysfunction

Rick A. Nishimura et al. JACC 2014;63:e57-e185

Connie W. Tsao et al. JCHF 2016;4:

Jeffrey J. Teuteberg et al. JCHF 2015;3:

Rick A. Nishimura et al. JACC 2014;63:e57-e185

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Kaplan-Meier estimation of diabetes-related survival curves in patients grouped according to increased 24-h proteinuria (A), the presence of preexisting.

Satoru Kishi et al. JCHF 2014;2:

Constantijn Franssen et al. JCHF 2016;4:

Medically Refractory Pulmonary Hypertension: Treatment With Nonpulsatile Left Ventricular Assist Devices Christian D. Etz, MD, Henryk A. Welp, MD, Tony.

Zeenat Safdar et al. JCHF 2014;2:

Maxime Berthelot-Richer et al. JIMG 2016;9:

Algorithm for haemodynamic evaluation in the elderly.

Orly Vardeny et al. JCHF 2016;4:

Philippe Pibarot et al. JIMG 2015;8:

Evan M. Zahn et al. JCIN 2016;9: Relationship Between Patent Ductus Arteriosus Closure and Left Ventricular Ejection Fraction The graph depicts.

Time to first event analysis revealed a significant difference in estimated event-free (death or hospitalisation) survival between patients with left ventricular.

Maria R. Costanzo et al. JCHF 2016;4:

Leah M. Wright et al. JIMG 2016;9:

Patient selection process in the present study.

Survival of subjects listed for heart transplantation with different spirometric ventilatory patterns. Survival of subjects listed for heart transplantation.

Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without.

Constantijn Franssen et al. JCHF 2016;4:

Presentation transcript:

Wayne L. Miller et al. JCHF 2013;1:290-299 Survival of HFREF Patients With PH (A) Kaplan-Meier estimates of survival in patients with heart failure of reduced left ventricular ejection fraction (HFREF) relative to passive pulmonary hypertension (PH) and mixed PH as defined by pulmonary vascular resistance (PVR) < or ≥3.0 Wood units (WU) and no PH. (B) Kaplan-Meier estimates of survival in patients with HFREF relative to passive PH and mixed PH as defined by transpulmonary gradient (TPG) < and ≥12 mm Hg and no PH. Wayne L. Miller et al. JCHF 2013;1:290-299 2013 American College of Cardiology Foundation